Johnson Investment Counsel Inc. Has $1.67 Million Stock Holdings in U.S. Physical Therapy, Inc. $USPH

Johnson Investment Counsel Inc. cut its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 1.5% in the second quarter, Holdings Channel.com reports. The fund owned 21,317 shares of the company’s stock after selling 333 shares during the quarter. Johnson Investment Counsel Inc.’s holdings in U.S. Physical Therapy were worth $1,667,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Copeland Capital Management LLC lifted its stake in U.S. Physical Therapy by 8.9% in the second quarter. Copeland Capital Management LLC now owns 888,735 shares of the company’s stock valued at $69,499,000 after acquiring an additional 72,463 shares during the last quarter. Bahl & Gaynor Inc. lifted its stake in U.S. Physical Therapy by 32.6% in the first quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company’s stock valued at $24,964,000 after acquiring an additional 84,878 shares during the last quarter. GW&K Investment Management LLC lifted its stake in U.S. Physical Therapy by 8.9% in the first quarter. GW&K Investment Management LLC now owns 344,390 shares of the company’s stock valued at $24,920,000 after acquiring an additional 28,203 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in U.S. Physical Therapy by 5.6% in the first quarter. Envestnet Asset Management Inc. now owns 316,489 shares of the company’s stock valued at $22,901,000 after acquiring an additional 16,698 shares during the last quarter. Finally, Northern Trust Corp raised its position in shares of U.S. Physical Therapy by 4.7% in the first quarter. Northern Trust Corp now owns 274,117 shares of the company’s stock valued at $19,835,000 after purchasing an additional 12,292 shares during the period.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Eric Joseph Williams sold 1,000 shares of U.S. Physical Therapy stock in a transaction on Friday, September 5th. The shares were sold at an average price of $85.25, for a total transaction of $85,250.00. Following the sale, the chief operating officer owned 25,331 shares in the company, valued at $2,159,467.75. The trade was a 3.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Christopher J. Reading sold 2,000 shares of U.S. Physical Therapy stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $83.53, for a total transaction of $167,060.00. Following the sale, the chief executive officer owned 114,088 shares in the company, valued at $9,529,770.64. This represents a 1.72% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,853 shares of company stock valued at $581,406 in the last three months. 2.00% of the stock is owned by insiders.

U.S. Physical Therapy Trading Up 1.0%

Shares of USPH stock opened at $88.64 on Tuesday. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $101.19. The firm’s fifty day simple moving average is $83.98 and its 200 day simple moving average is $77.53. The firm has a market capitalization of $1.35 billion, a P/E ratio of 38.71, a price-to-earnings-growth ratio of 4.40 and a beta of 1.48. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Tuesday, August 22nd. The company reported $0.90 earnings per share (EPS) for the quarter. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The business had revenue of $140.66 million for the quarter. As a group, sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 dividend on an annualized basis and a yield of 2.0%. U.S. Physical Therapy’s payout ratio is 78.60%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Barrington Research lifted their price target on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the company an “outperform” rating in a research report on Friday, August 8th. Wall Street Zen lowered shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research report on Sunday, September 21st. Zacks Research raised shares of U.S. Physical Therapy to a “hold” rating in a research report on Friday, August 8th. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. assumed coverage on shares of U.S. Physical Therapy in a research report on Thursday, September 18th. They issued an “overweight” rating and a $110.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $110.25.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.